OTC
STJ

Opera Trading Capital’s St Jude Medical STJ Stock Holding History

Opera Trading Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-31,782
Closed -$2.55M – 144
2016
Q4 		$2.55M Sell
31,782
-20,600
-39% -$1.64M 0.77% 44
2016
Q3 		$4.18M Sell
52,382
-14,500
-22% -$1.17M 0.88% 39
2016
Q2 		$5.22M Buy
+66,882
New +$4.77M 1.13% 31

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Opera Trading Capital's STJ Position: Q1 2017 in Review

Opera Trading Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 31,782 shares — an estimated $2.55M sold.

Opera Trading Capital first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $5.22M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Opera Trading Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Opera Trading Capital sold 31,782 St Jude Medical shares in Q1 2017, an estimated $2.55M.
  • Opera Trading Capital first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Opera Trading Capital's St Jude Medical position peaked at $5.22M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Opera Trading Capital's 13F filing for Q1 2017, filed 3 May 2017.